[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349970-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349970-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","chemical-constituents-of-rhazya-stricta-as-potential-aurora-kinase-a-inhibitors-for-targeting-her2-negative-breast-cancer-an-integrated-in-silico-and-in-vitro-study","Chemical constituents of Rhazya stricta as potential Aurora kinase A inhibitors for targeting HER2-negative breast cancer - an integrated in-silico and in-vitro study","","HER2-negative breast cancer is a breast cancer type that does not overexpress the HER2 protein, and conventional drug design methods are being complemented by computational-aided drug discovery (CADD). This work evaluates phytochemicals from Rhazya stricta as potential Aurora kinase A (AURKA) inhibitors using molecular docking, Prime MM-GBSA, and molecular dynamics simulations to estimate binding energies and stability. Five of 27 screened compounds showed stable complexes and strong binding scores, suggesting lead potential. Cell viability, inhibition, and cytotoxicity were assessed by an MTT assay.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/chemical-constituents-of-rhazya-stricta-as-potential-aurora-kinase-a-inhibitors-for-targeting-her2-negative-breast-cancer-an-integrated-in-silico-and-in-vitro-study/349970/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/chemical-constituents-of-rhazya-stricta-as-potential-aurora-kinase-a-inhibitors-for-targeting-her2-negative-breast-cancer-an-integrated-in-silico-and-in-vitro-study/349970.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are HER2-negative breast cancer and AURKA considered in this study?","Question",{"text":63,"@type":64},"HER2-negative breast cancer does not overexpress the HER2 protein. The study targets Aurora kinase A (AURKA) because AURKA is used as the drug-discovery target for potential therapeutic effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What computational methods were used to screen Rhazya stricta phytochemicals?",{"text":68,"@type":64},"The study used molecular docking, Prime MM-GBSA, and molecular dynamics (MD) simulations to evaluate binding energies and fluctuating stability of ligands with the target protein.",{"name":70,"@type":61,"acceptedAnswer":71},"Which experimental assay was used to validate the phytochemicals’ effects?",{"text":72,"@type":64},"An MTT assay was performed to confirm cell viability, cell inhibition, and cytotoxicity of the phytochemicals present in the plant extract.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349970,1790167331,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Yusaf etal. BMC Complementary Medicine and Therapies (2026) 26:98  \n[https://doi.org/10.1186/s12906-025-05218-w](https://doi.org/10.1186/s12906-025-05218-w)  \nBMC Complementary Medicine and Therapies  \nRESEARCH Open Access  \nChemical constituents of Rhazya stricta as potential Aurora kinase A inhibitors for targeting HER2-negative breast cancer: an integrated in-silico and in-vitro study  \nIkhlas Yusaf1†, Nirmal Malik 1†, Abrar Ahmed1*† and Hamid Saeed1†  \nAbstract  \nHuman Epidermal Growth Factor Receptor 2 (HER2) negative breast cancer is a type of breast cancer that does not overexpress the HER2 protein. In some breast cancers, overexpression of HER2 makes the cancer more aggressive. Computational-aided drug discovery (CADD) was taken as an efficient alternative to conventional methods of drug design and development. This study has also been carried out using the same drug design and development methods from Rhazya stricta; whose extracts are traditionally approved to possess anti-cancer activity while choosing Aurora Kinase A (AURKA) as our target of interest. Phytochemicals present in Rhazya stricta were found from already published literature, to be tested as potential AURKA inhibitors through molecular docking, Prime MM-GBSA, and Molecular Dynamic (MD) simulations to know about the binding energies and fluctuating stability of ligands with protein. Five out of twenty-seven screened compounds showed stable complexes and remarkable binding scores ranging between − 6.569 kcal/Mol to-5.371 kcal/Mol with the target protein so can be investigated as potential lead compounds to treat HER2-negative breast cancer. The in-silico techniques employed successfully identified phytochemicals with potent human AURKA inhibitory properties. Compounds (6), (8), (5), (4),(1) as AURKA inhibitors have the potential to block AURKA by targeting p53 tumor-suppressing protein to prevent the further development of tumors. The MTT assay was performed to confirm the cell viability, cell inhibition, and cytotoxicity of the phytochemicals present in the plant extract.  \nKeywords AURKA, HER2-negative breast cancer, Molecular docking, CADD, SBDD, MM-GBSA, Molecular dynamic simulations, MTT assay, Rhazya stricta, Phytochemicals, LC-MS, In-silico, In-vivo  \n†Ikhlas Yusaf, Nirmal Malik, Abrar Ahmed and Hamid Saeed are contributed equally to this work.  \n*Correspondence:  \nAbrar Ahmed  \n[abrar.pharmacy@pu.edu.pk](abrar.pharmacy@pu.edu.pk)  \n1Faculty of Pharmacy, Punjab University College of Pharmacy, University of the Punjab, Lahore 54590, Pakistan  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nYusaf et al. BMC Complementary Medicine and Therapies (2026) 26:98 Page 2 of 15  \nIntroduction  \nCancer is a disease characterized by the abnormal proliferation of any of the several different types of cells in the body. In Pakistan, the most common malignancy diagnosed in women is breas","cbCaih2B32QKIDNQ","https://ap.wps.com/l/cbCaih2B32QKIDNQ","pdf",2679441,15,"English","# Abstract\n# Introduction","[{\"question\":\"Why are HER2-negative breast cancer and AURKA considered in this study?\",\"answer\":\"HER2-negative breast cancer does not overexpress the HER2 protein. The study targets Aurora kinase A (AURKA) because AURKA is used as the drug-discovery target for potential therapeutic effects.\"},{\"question\":\"What computational methods were used to screen Rhazya stricta phytochemicals?\",\"answer\":\"The study used molecular docking, Prime MM-GBSA, and molecular dynamics (MD) simulations to evaluate binding energies and fluctuating stability of ligands with the target protein.\"},{\"question\":\"Which experimental assay was used to validate the phytochemicals’ effects?\",\"answer\":\"An MTT assay was performed to confirm cell viability, cell inhibition, and cytotoxicity of the phytochemicals present in the plant extract.\"}]","Chemical constituents of Rhazya stricta as potential Aurora kinase A inhibitors for targeting HER2-negative breast cancer - an integrated in-silico and in-vitro study | PDF",1790086522,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae060ca279826c97c7fde6beb5f24420.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04c1d51a9cefbe10b60cca9550eb1840.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59270f228cee8a44be0c9f54eb040c2c.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6903fb0c84ee703a174f0092139745c8.webp",980,1306]